Occupe actuellement des postes chez La Jolla Pharmaceutical Co, Odonate Therapeutics Inc and Heron Therapeutics Inc
Position | Company | Period |
---|---|---|
Chairman of the Board | La Jolla Pharmaceutical Co | 1 août 2014 - |
Chairman of the Board, Chief Executive Officer | Odonate Therapeutics Inc | 1 janvier 2013 - |
Independent Chairman of the Board | Heron Therapeutics Inc | 30 juillet 2012 - |
Independent Director | Heron Therapeutics Inc | 8 février 2009 - 30 juillet 2012 |
Independent Director | Ardea Biosciences Inc | 1 mai 2003 - 19 juin 2012 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-12-18 | 2023-12-18 |
Rain Therapeutics Inc
(RAIN)
|
V Vente |
40 132
-1.0%
1,2148 560 USD |
40 132 -1.0% | 1,21 | 48 560 USD | |
2023-12-18 | 2023-12-15 |
Rain Therapeutics Inc
(RAIN)
|
V Vente |
109 435
-2.7%
1,20131 322 USD |
109 435 -2.7% | 1,20 | 131 322 USD | |
2023-12-18 | 2023-12-14 |
Rain Therapeutics Inc
(RAIN)
|
V Vente |
24 406
-0.6%
1,2129 531 USD |
24 406 -0.6% | 1,21 | 29 531 USD | |
2023-10-13 | 2023-10-13 |
Rain Therapeutics Inc
(RAIN)
|
A Achat |
84 145
+2.1%
0,9983 304 USD |
84 145 +2.1% | 0,99 | 83 304 USD | |
2023-10-13 | 2023-10-13 |
Rain Therapeutics Inc
(RAIN)
|
A Achat |
47 486
+1.2%
0,9947 011 USD |
47 486 +1.2% | 0,99 | 47 011 USD | |
2023-10-13 | 2023-10-12 |
Rain Therapeutics Inc
(RAIN)
|
A Achat |
52 514
+1.4%
0,9851 464 USD |
52 514 +1.4% | 0,98 | 51 464 USD | |
2023-10-13 | 2023-10-12 |
Rain Therapeutics Inc
(RAIN)
|
A Achat |
25 188
+0.7%
0,9824 684 USD |
25 188 +0.7% | 0,98 | 24 684 USD | |
2023-10-13 | 2023-10-11 |
Rain Therapeutics Inc
(RAIN)
|
A Achat |
74 812
+2.0%
0,9772 568 USD |
74 812 +2.0% | 0,97 | 72 568 USD | |
2023-06-01 | 2023-06-01 |
Rain Therapeutics Inc
(RAIN)
|
A Achat |
240 341
+6.9%
1,12269 182 USD |
240 341 +6.9% | 1,12 | 269 182 USD | |
2023-06-01 | 2023-06-01 |
Rain Therapeutics Inc
(RAIN)
|
A Achat |
92 984
+2.7%
1,09101 353 USD |
92 984 +2.7% | 1,09 | 101 353 USD | |
2023-06-01 | 2023-05-30 |
Rain Therapeutics Inc
(RAIN)
|
A Achat |
2 016
+0.1%
1,082 177 USD |
2 016 +0.1% | 1,08 | 2 177 USD | |
2023-06-01 | 2023-05-30 |
Rain Therapeutics Inc
(RAIN)
|
A Achat |
32 890
+1.0%
1,0634 863 USD |
32 890 +1.0% | 1,06 | 34 863 USD | |
2023-06-01 | 2023-05-30 |
Rain Therapeutics Inc
(RAIN)
|
A Achat |
200 000
+6.7%
1,00200 000 USD |
200 000 +6.7% | 1,00 | 200 000 USD | |
2023-06-01 | 2023-05-30 |
Rain Therapeutics Inc
(RAIN)
|
A Achat |
347 932
+13.1%
1,05365 329 USD |
347 932 +13.1% | 1,05 | 365 329 USD | |
2023-05-30 | 2023-05-25 |
TCR2 Therapeutics Inc
(TCRR)
|
A Achat |
50 000
+1.2%
1,7286 000 USD |
50 000 +1.2% | 1,72 | 86 000 USD | |
2023-05-15 | 2023-05-12 |
TCR2 Therapeutics Inc
(TCRR)
|
A Achat |
6 183
+0.1%
1,9512 057 USD |
6 183 +0.1% | 1,95 | 12 057 USD | |
2023-05-15 | 2023-05-11 |
TCR2 Therapeutics Inc
(TCRR)
|
A Achat |
38 765
+0.9%
1,9575 592 USD |
38 765 +0.9% | 1,95 | 75 592 USD | |
2023-05-10 | 2023-05-10 |
TCR2 Therapeutics Inc
(TCRR)
|
A Achat |
6 774
+0.2%
1,9513 209 USD |
6 774 +0.2% | 1,95 | 13 209 USD | |
2023-05-10 | 2023-05-09 |
TCR2 Therapeutics Inc
(TCRR)
|
A Achat |
20 141
+0.5%
1,9539 275 USD |
20 141 +0.5% | 1,95 | 39 275 USD | |
2023-05-10 | 2023-05-08 |
TCR2 Therapeutics Inc
(TCRR)
|
A Achat |
57 073
+1.4%
1,95111 292 USD |
57 073 +1.4% | 1,95 | 111 292 USD | |
2023-05-05 | 2023-05-05 |
TCR2 Therapeutics Inc
(TCRR)
|
A Achat |
71 064
+1.7%
1,94137 864 USD |
71 064 +1.7% | 1,94 | 137 864 USD | |
2023-05-05 | 2023-05-05 |
TCR2 Therapeutics Inc
(TCRR)
|
A Achat |
95 759
+2.4%
1,90181 942 USD |
95 759 +2.4% | 1,90 | 181 942 USD | |
2023-05-05 | 2023-05-04 |
TCR2 Therapeutics Inc
(TCRR)
|
A Achat |
104 241
+2.6%
1,86193 888 USD |
104 241 +2.6% | 1,86 | 193 888 USD | |
2023-05-05 | 2023-05-03 |
TCR2 Therapeutics Inc
(TCRR)
|
A Achat |
18 513
+0.5%
1,8534 249 USD |
18 513 +0.5% | 1,85 | 34 249 USD | |
2023-03-14 | 2023-03-14 |
Jounce Therapeutics Inc
(JNCE)
|
A Achat |
20 286
+0.4%
1,0220 651 USD |
20 286 +0.4% | 1,02 | 20 651 USD | |
2023-03-14 | 2023-03-13 |
Jounce Therapeutics Inc
(JNCE)
|
A Achat |
65 701
+1.3%
0,9965 307 USD |
65 701 +1.3% | 0,99 | 65 307 USD | |
2021-12-01 | 2021-12-01 |
La Jolla Pharmaceutical Co
(LJPC)
|
V Vente |
41 290
-0.4%
3,66151 303 USD |
41 290 -0.4% | 3,66 | 151 303 USD | |
2021-12-01 | 2021-12-01 |
La Jolla Pharmaceutical Co
(LJPC)
|
V Vente |
136 255
-1.4%
3,76512 128 USD |
136 255 -1.4% | 3,76 | 512 128 USD | |
2021-12-01 | 2021-11-30 |
La Jolla Pharmaceutical Co
(LJPC)
|
V Vente |
63 745
-0.6%
3,95251 544 USD |
63 745 -0.6% | 3,95 | 251 544 USD | |
2021-12-01 | 2021-11-30 |
La Jolla Pharmaceutical Co
(LJPC)
|
V Vente |
6 597
-0.1%
3,9526 067 USD |
6 597 -0.1% | 3,95 | 26 067 USD | |
2021-12-01 | 2021-11-29 |
La Jolla Pharmaceutical Co
(LJPC)
|
V Vente |
193 403
-1.9%
4,10793 107 USD |
193 403 -1.9% | 4,10 | 793 107 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
160 000
-100.0%
9,601 536 560 USD |
160 000 -100.0% | 9,60 | 1 536 560 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
200 000
-55.6%
10,072 014 440 USD |
200 000 -55.6% | 10,07 | 2 014 440 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
50 889
-12.4%
10,43530 665 USD |
50 889 -12.4% | 10,43 | 530 665 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
149 111
-26.6%
11,191 668 433 USD |
149 111 -26.6% | 11,19 | 1 668 433 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
75 491
-11.9%
11,74886 430 USD |
75 491 -11.9% | 11,74 | 886 430 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
124 509
-16.4%
12,451 550 187 USD |
124 509 -16.4% | 12,45 | 1 550 187 USD | |
2021-11-26 | 2021-11-23 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
161 336
-17.5%
13,522 181 521 USD |
161 336 -17.5% | 13,52 | 2 181 521 USD | |
2021-11-22 | 2021-11-22 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
38 664
-4.0%
6,55253 373 USD |
38 664 -4.0% | 6,55 | 253 373 USD | |
2021-11-22 | 2021-11-22 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
3 719
-0.4%
6,6624 779 USD |
3 719 -0.4% | 6,66 | 24 779 USD | |
2021-11-22 | 2021-11-22 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
196 281
-16.9%
7,111 395 185 USD |
196 281 -16.9% | 7,11 | 1 395 185 USD | |
2021-11-22 | 2021-11-22 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
16 667
-1.4%
7,36122 651 USD |
16 667 -1.4% | 7,36 | 122 651 USD | |
2021-11-22 | 2021-11-19 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
183 333
-13.5%
7,521 378 756 USD |
183 333 -13.5% | 7,52 | 1 378 756 USD | |
2021-11-22 | 2021-11-19 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
30 467
-2.2%
8,01244 111 USD |
30 467 -2.2% | 8,01 | 244 111 USD | |
2021-11-19 | 2021-11-19 |
Odonate Therapeutics Inc
(ODT)
|
V Vente |
365 289
-2.8%
1,92699 930 USD |
365 289 -2.8% | 1,92 | 699 930 USD | |
2021-11-22 | 2021-11-18 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
169 533
-10.9%
8,091 372 319 USD |
169 533 -10.9% | 8,09 | 1 372 319 USD | |
2021-11-22 | 2021-11-18 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
4 023
-0.3%
8,0032 190 USD |
4 023 -0.3% | 8,00 | 32 190 USD | |
2021-11-22 | 2021-11-18 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
152 764
-8.9%
8,321 271 516 USD |
152 764 -8.9% | 8,32 | 1 271 516 USD | |
2021-11-22 | 2021-11-18 |
Aptevo Therapeutics Inc
(APVO)
|
V Vente |
43 213
-2.5%
9,38405 532 USD |
43 213 -2.5% | 9,38 | 405 532 USD | |
2021-11-19 | 2021-11-18 |
Odonate Therapeutics Inc
(ODT)
|
V Vente |
381 842
-2.8%
1,89722 636 USD |
381 842 -2.8% | 1,89 | 722 636 USD | |
2021-11-19 | 2021-11-18 |
Odonate Therapeutics Inc
(ODT)
|
V Vente |
500 000
-3.6%
1,88940 600 USD |
500 000 -3.6% | 1,88 | 940 600 USD | |
2021-11-19 | 2021-11-18 |
Odonate Therapeutics Inc
(ODT)
|
V Vente |
212 423
-1.5%
1,97418 643 USD |
212 423 -1.5% | 1,97 | 418 643 USD | |
2021-11-19 | 2021-11-17 |
Odonate Therapeutics Inc
(ODT)
|
V Vente |
287 577
-2.0%
2,20632 238 USD |
287 577 -2.0% | 2,20 | 632 238 USD | |
2021-11-19 | 2021-11-17 |
Odonate Therapeutics Inc
(ODT)
|
V Vente |
500 000
-3.3%
2,021 008 050 USD |
500 000 -3.3% | 2,02 | 1 008 050 USD | |
2021-11-19 | 2021-11-17 |
Odonate Therapeutics Inc
(ODT)
|
V Vente |
31 151
-0.2%
1,9962 118 USD |
31 151 -0.2% | 1,99 | 62 118 USD | |
2021-11-19 | 2021-11-17 |
Odonate Therapeutics Inc
(ODT)
|
V Vente |
468 849
-3.0%
2,661 246 341 USD |
468 849 -3.0% | 2,66 | 1 246 341 USD | |
2021-05-26 | 2021-05-26 |
La Jolla Pharmaceutical Co
(LJPC)
|
A Achat |
166 932
+1.7%
4,26710 763 USD |
166 932 +1.7% | 4,26 | 710 763 USD | |
2021-05-26 | 2021-05-25 |
La Jolla Pharmaceutical Co
(LJPC)
|
A Achat |
31 782
+0.3%
3,83121 874 USD |
31 782 +0.3% | 3,83 | 121 874 USD | |
2021-05-26 | 2021-05-25 |
La Jolla Pharmaceutical Co
(LJPC)
|
A Achat |
95 597
+1.0%
3,77360 860 USD |
95 597 +1.0% | 3,77 | 360 860 USD | |
2021-05-26 | 2021-05-24 |
La Jolla Pharmaceutical Co
(LJPC)
|
A Achat |
104 403
+1.1%
3,68384 234 USD |
104 403 +1.1% | 3,68 | 384 234 USD | |
2020-12-23 | 2020-12-23 |
Odonate Therapeutics Inc
(ODT)
|
A Achat |
75 784
+0.5%
15,711 190 415 USD |
75 784 +0.5% | 15,71 | 1 190 415 USD | |
2020-12-23 | 2020-12-23 |
Odonate Therapeutics Inc
(ODT)
|
A Achat |
63 354
+0.4%
15,43977 438 USD |
63 354 +0.4% | 15,43 | 977 438 USD | |
2020-12-23 | 2020-12-22 |
Odonate Therapeutics Inc
(ODT)
|
A Achat |
36 646
+0.2%
15,17555 821 USD |
36 646 +0.2% | 15,17 | 555 821 USD | |
2020-12-23 | 2020-12-22 |
Odonate Therapeutics Inc
(ODT)
|
A Achat |
37 856
+0.2%
14,58551 766 USD |
37 856 +0.2% | 14,58 | 551 766 USD | |
2020-12-23 | 2020-12-21 |
Odonate Therapeutics Inc
(ODT)
|
A Achat |
62 144
+0.4%
14,58905 767 USD |
62 144 +0.4% | 14,58 | 905 767 USD | |
2020-11-06 | 2020-11-06 |
Aptevo Therapeutics Inc
(APVO)
|
A Achat |
2 650
+0.2%
23,8763 256 USD |
2 650 +0.2% | 23,87 | 63 256 USD | |
2020-11-06 | 2020-11-06 |
Aptevo Therapeutics Inc
(APVO)
|
A Achat |
107 901
+6.5%
23,482 533 515 USD |
107 901 +6.5% | 23,48 | 2 533 515 USD | |
2020-11-06 | 2020-11-06 |
Aptevo Therapeutics Inc
(APVO)
|
A Achat |
29 682
+1.8%
22,33662 799 USD |
29 682 +1.8% | 22,33 | 662 799 USD | |
2020-11-06 | 2020-11-06 |
Aptevo Therapeutics Inc
(APVO)
|
A Achat |
34 044
+2.1%
20,63702 328 USD |
34 044 +2.1% | 20,63 | 702 328 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
A Achat |
8 482
+0.5%
20,94177 613 USD |
8 482 +0.5% | 20,94 | 177 613 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
A Achat |
137 241
+9.5%
20,782 851 868 USD |
137 241 +9.5% | 20,78 | 2 851 868 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
A Achat |
171 626
+13.5%
23,794 082 983 USD |
171 626 +13.5% | 23,79 | 4 082 983 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
A Achat |
71 241
+6.0%
15,321 091 412 USD |
71 241 +6.0% | 15,32 | 1 091 412 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
A Achat |
77 133
+6.9%
14,221 096 831 USD |
77 133 +6.9% | 14,22 | 1 096 831 USD | |
2020-11-06 | 2020-11-05 |
Aptevo Therapeutics Inc
(APVO)
|
A Achat |
160 000
+16.7%
15,312 449 600 USD |
160 000 +16.7% | 15,31 | 2 449 600 USD |